These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 8020685)

  • 21. Detection of occult hepatitis C and hepatitis B virus infections from peripheral blood mononuclear cells.
    Zaghloul H; El-Sherbiny W
    Immunol Invest; 2010 Jan; 39(3):284-91. PubMed ID: 20380524
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interleukin 2 treatment does not modify hepatitis B or C replication in human immunodeficiency virus-infected patients: results from a randomized control trial.
    Thibault V; Delaugerre C; Calvez V; Costagliola D; Tubiana R; Katlama C
    Hepatology; 2002 Jan; 35(1):238-9. PubMed ID: 11786983
    [No Abstract]   [Full Text] [Related]  

  • 23. [Molecular diagnosis of hepatitis B virus and hepatitis C virus infection].
    Nomura F; Itoga S
    Rinsho Byori; 2002 Nov; Suppl 123():31-6. PubMed ID: 12652787
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pathophysiology of hepatitis C virus infection.
    Camps J; Córdoba J; Esteban JI
    Pathol Biol (Paris); 1995 Oct; 43(8):691-702. PubMed ID: 8745591
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Impact of calcium signaling in liver carcinogenesis].
    Chami M; Benali NL; Bréchot C; Paterlini-Bréchot P
    Med Sci (Paris); 2007 Feb; 23(2):133-5. PubMed ID: 17291421
    [No Abstract]   [Full Text] [Related]  

  • 26. [Ultrastructural reactions of liver cell populations during exposure to RNA- and DNA-genomic hepatitis C+B virus].
    Nepomniashchikh GI; Tolokonskaia NP; Aĭdagulova SV; Nepomniashchikh DL; Sakharova EG; Mezentseva GA; Savchenko IaE
    Biull Eksp Biol Med; 1999 Jul; 128(7):101-5. PubMed ID: 10485065
    [No Abstract]   [Full Text] [Related]  

  • 27. Profound suppression of chronic hepatitis C following superinfection with hepatitis B virus.
    Coffin CS; Mulrooney-Cousins PM; Lee SS; Michalak TI; Swain MG
    Liver Int; 2007 Jun; 27(5):722-6. PubMed ID: 17498260
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Hepatitis B and C virus mutants--clinical relevance].
    Blum HE
    Schweiz Rundsch Med Prax; 1994 Sep; 83(36):1000-4. PubMed ID: 7939054
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro replication models for the hepatitis C virus.
    Sheehy P; Mullan B; Moreau I; Kenny-Walsh E; Shanahan F; Scallan M; Fanning LJ
    J Viral Hepat; 2007 Jan; 14(1):2-10. PubMed ID: 17212638
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The hepatitis B virus and the peripheral blood mononuclear cells: a brief review.
    Lamelin JP; Trépo C
    J Hepatol; 1990 Jan; 10(1):120-4. PubMed ID: 2407771
    [No Abstract]   [Full Text] [Related]  

  • 31. Profile of patients triply infected with HIV and the hepatitis B and C viruses in the HAART era.
    Maida I; Ríos MJ; Pérez-Saleme L; Ramos B; Soriano V; Pegram PS; Mura MS; Sánchez-Margalet V; Saldívar-Cornejo I; Wilkin A; Babudieri S; Núñez M
    AIDS Res Hum Retroviruses; 2008 May; 24(5):679-83. PubMed ID: 18462085
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The replication cycle of hepatitis B virus.
    Urban S; Schulze A; Dandri M; Petersen J
    J Hepatol; 2010 Feb; 52(2):282-4. PubMed ID: 20056291
    [No Abstract]   [Full Text] [Related]  

  • 33. Hepatitis C virus replication cycle.
    Bartenschlager R; Cosset FL; Lohmann V
    J Hepatol; 2010 Sep; 53(3):583-5. PubMed ID: 20579761
    [No Abstract]   [Full Text] [Related]  

  • 34. Hepatitis C and B virus infections in hepatocellular carcinoma. Analysis of direct detection of viral genome in paraffin embedded tissues.
    Edamoto Y; Tani M; Kurata T; Abe K
    Cancer; 1996 May; 77(9):1787-91. PubMed ID: 8646675
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Distribution of HCV genotypes and its clinical features in patients coinfected with HCV and HBV].
    Jiao J; Wang JB; Zhao P
    Zhonghua Gan Zang Bing Za Zhi; 2003 Nov; 11(11):688. PubMed ID: 14636450
    [No Abstract]   [Full Text] [Related]  

  • 36. [Using RNA interference to treat hepatitis virus: hope for future development].
    Wei L
    Zhonghua Gan Zang Bing Za Zhi; 2004 Sep; 12(9):555. PubMed ID: 15387911
    [No Abstract]   [Full Text] [Related]  

  • 37. Two core promotor mutations identified in a hepatitis B virus strain associated with fulminant hepatitis result in enhanced viral replication.
    Baumert TF; Rogers SA; Hasegawa K; Liang TJ
    J Clin Invest; 1996 Nov; 98(10):2268-76. PubMed ID: 8941643
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low replication and variability of HBV pre-core in concomitant infection with hepatitis B and hepatitis C viruses.
    De Mitri MS; Morsica G; Cassini R; Bagaglio S; Andreone P; Bianchi G; Loggi E; Bernardi M
    Arch Virol; 2007 Feb; 152(2):395-404. PubMed ID: 16953307
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Virological and clinical aspects of HBV-HCV coinfection in HIV positive patients.
    Filippini P; Coppola N; Pisapia R; Martini S; Marrocco C; Di Martino F; Sagnelli C; Filippini A; Sagnelli E
    J Med Virol; 2007 Nov; 79(11):1679-85. PubMed ID: 17854026
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular diagnostic techniques for viral hepatitis.
    Hu KQ; Vierling JM
    Gastroenterol Clin North Am; 1994 Sep; 23(3):479-98. PubMed ID: 7989090
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.